您的购物车当前为空
别名 NLG-919 analogue, NLG919, Navoximod, GDC-0919
IDO-IN-7 (NLG-919 analogue) 是 IDO1 抑制剂,IC50=38 nM。

IDO-IN-7 (NLG-919 analogue) 是 IDO1 抑制剂,IC50=38 nM。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 119 | In Stock | |
| 5 mg | ¥ 247 | In Stock | |
| 10 mg | ¥ 413 | In Stock | |
| 25 mg | ¥ 745 | In Stock | |
| 50 mg | ¥ 1,230 | In Stock | |
| 100 mg | ¥ 1,980 | In Stock | |
| 200 mg | ¥ 2,970 | In Stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 272 | In Stock |
IDO-IN-7 相关产品
| 产品描述 | IDO-IN-7 (NLG-919 analogue) is a potent IDO (indoleamine-(2, 3)-dioxygenase) pathway inhibitor. |
| 靶点活性 | IDO:75 nM(EC50) |
| 体外活性 | 在含B16F10瘤的小鼠中,NLG919明显增强了pmel-1静息细胞对同源hgp100肽和CpG-1826的抗肿瘤反应. |
| 体内活性 | NLG919能够显著阻断IDO诱导的T细胞抑制作用,恢复的T细胞反应(ED50=80 nM)。 在来自肿瘤淋巴结的表达IDO的小鼠DC细胞(ED50=120 nM),NLG919消除IDO诱导的抗原特异性T细胞(OT-1)抑制。 |
| 别名 | NLG-919 analogue, NLG919, Navoximod, GDC-0919 |
| 分子量 | 282.38 |
| 分子式 | C18H22N2O |
| CAS No. | 1402836-58-1 |
| Smiles | OC(CC1c2ccccc2-c2cncn12)C1CCCCC1 |
| 密度 | 1.27 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| 溶解度信息 | Ethanol: 26 mg/mL (92.07 mM), Sonication is recommended. DMSO: 45 mg/mL (159.36 mM), Sonication is recommended. H2O: < 1 mg/mL (insoluble or slightly soluble) | ||||||||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (7.08 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
DMSO
| |||||||||||||||||||||||||||||||||||||||||
评论内容